Table 3.

Total co-administration of anti-SARS-CoV-2 and influenza vaccines in 2021/2022 and 2022/2023 campaigns by age category.

	2021/2022		2022/2023
Professional category	N	N (%)	N	N (%)	Percent change (%)	p-value
23–31	263	17.57	209	64.91	269.44	<.001*
32–41	182	13.97	164	52.23	273.87	<.001*
42–52	159	10.43	204	47.44	354.84	<.001*
53–84	191	12.47	289	46.69	274.42	<.001*
Tot	795	13.58	866	51.39	278.42	<.001*

*Statistically significant value.